⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for mucinous adenocarcinoma of the rectum

Every month we try and update this database with for mucinous adenocarcinoma of the rectum cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by SurgeryNCT00835679
Liver Metastase...
Mucinous Adenoc...
Mucinous Adenoc...
Recurrent Colon...
Recurrent Recta...
Signet Ring Ade...
Signet Ring Ade...
Stage IV Colon ...
Stage IV Rectal...
cetuximab
dasatinib
therapeutic con...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With BevacizumabNCT01814501
Mucinous Adenoc...
Mucinous Adenoc...
Recurrent Colon...
Recurrent Recta...
Signet Ring Ade...
Signet Ring Ade...
Stage IV Colon ...
Stage IV Rectal...
panitumumab
irinotecan hydr...
fluorouracil
leucovorin calc...
18 Years - Ohio State University Comprehensive Cancer Center
Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal CancerNCT00002796
Mucinous Adenoc...
Mucinous Adenoc...
Recurrent Colon...
Recurrent Recta...
Signet Ring Ade...
Signet Ring Ade...
Stage IVA Colon...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Recta...
fluorouracil
sodium phenylbu...
indomethacin
recombinant int...
- National Cancer Institute (NCI)
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal MalignanciesNCT01643499
Acinar Cell Ade...
Adenocarcinoma ...
Adenocarcinoma ...
Adult Primary C...
Advanced Adult ...
Cholangiocarcin...
Cholangiocarcin...
Diffuse Adenoca...
Duct Cell Adeno...
Intestinal Aden...
Localized Unres...
Metastatic Carc...
Metastatic Extr...
Mixed Adenocarc...
Mucinous Adenoc...
Mucinous Adenoc...
Newly Diagnosed...
Signet Ring Ade...
Signet Ring Ade...
Stage III Pancr...
Stage IIIA Colo...
Stage IIIA Gall...
Stage IIIA Gast...
Stage IIIA Rect...
Stage IIIB Colo...
Stage IIIB Gall...
Stage IIIB Gast...
Stage IIIB Rect...
Stage IIIC Colo...
Stage IIIC Gast...
Stage IIIC Rect...
Stage IV Gastri...
Stage IV Pancre...
Stage IVA Colon...
Stage IVA Gallb...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Gallb...
Stage IVB Recta...
Unresectable Ex...
oxaliplatin
irinotecan hydr...
leucovorin calc...
fluorouracil
laboratory biom...
18 Years - University of Chicago
Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal CancerNCT01871571
Mucinous Adenoc...
Signet Ring Ade...
Stage IIA Recta...
Stage IIB Recta...
Stage IIC Recta...
Stage IIIA Rect...
Stage IIIB Rect...
Stage IIIC Rect...
bevacizumab
oxaliplatin
leucovorin calc...
fluorouracil
laboratory biom...
18 Years - University of Southern California
A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal CancerNCT00060411
Mucinous Adenoc...
Mucinous Adenoc...
Recurrent Colon...
Recurrent Recta...
Signet Ring Ade...
Signet Ring Ade...
Stage IIIA Colo...
Stage IIIA Rect...
Stage IIIB Colo...
Stage IIIB Rect...
Stage IIIC Colo...
Stage IIIC Rect...
Stage IVA Colon...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Recta...
erlotinib hydro...
fluorouracil
leucovorin calc...
oxaliplatin
bevacizumab
18 Years - National Cancer Institute (NCI)
Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal CancerNCT01923337
Mucinous Adenoc...
Mucinous Adenoc...
Recurrent Colon...
Recurrent Recta...
Signet Ring Ade...
Signet Ring Ade...
Stage IIIA Colo...
Unspecified Adu...
irinotecan hydr...
alisertib
18 Years - University of California, Davis
Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the LiverNCT02110953
Liver Metastase...
Mucinous Adenoc...
Mucinous Adenoc...
Recurrent Colon...
Recurrent Recta...
Signet Ring Ade...
Signet Ring Ade...
Stage IVA Colon...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Recta...
irinotecan-elut...
hepatic artery ...
18 Years - Fox Chase Cancer Center
Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal CancerNCT00002796
Mucinous Adenoc...
Mucinous Adenoc...
Recurrent Colon...
Recurrent Recta...
Signet Ring Ade...
Signet Ring Ade...
Stage IVA Colon...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Recta...
fluorouracil
sodium phenylbu...
indomethacin
recombinant int...
- National Cancer Institute (NCI)
Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerNCT00005036
Mucinous Adenoc...
Mucinous Adenoc...
Recurrent Colon...
Recurrent Recta...
Signet Ring Ade...
Signet Ring Ade...
Stage IIIA Colo...
Stage IIIA Rect...
Stage IIIB Colo...
Stage IIIB Rect...
Stage IIIC Colo...
Stage IIIC Rect...
Stage IVA Colon...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Recta...
irinotecan hydr...
oxaliplatin
leucovorin calc...
fluorouracil
quality-of-life...
18 Years - National Cancer Institute (NCI)
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing ChemotherapyNCT01079780
Colorectal Canc...
cetuximab
ramucirumab
irinotecan hydr...
18 Years - Eastern Cooperative Oncology Group
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing ChemotherapyNCT01079780
Colorectal Canc...
cetuximab
ramucirumab
irinotecan hydr...
18 Years - Eastern Cooperative Oncology Group
Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerNCT00005036
Mucinous Adenoc...
Mucinous Adenoc...
Recurrent Colon...
Recurrent Recta...
Signet Ring Ade...
Signet Ring Ade...
Stage IIIA Colo...
Stage IIIA Rect...
Stage IIIB Colo...
Stage IIIB Rect...
Stage IIIC Colo...
Stage IIIC Rect...
Stage IVA Colon...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Recta...
irinotecan hydr...
oxaliplatin
leucovorin calc...
fluorouracil
quality-of-life...
18 Years - National Cancer Institute (NCI)
Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal CancerNCT00002896
Colorectal Canc...
chemotherapy
fluorouracil
leucovorin calc...
conventional su...
low-LET cobalt-...
low-LET photon ...
- 75 YearsNational Cancer Institute (NCI)
Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal CancerNCT02235324
Mucinous Adenoc...
Mucinous Adenoc...
Recurrent Colon...
Recurrent Recta...
Signet Ring Ade...
Signet Ring Ade...
Stage IVA Colon...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Recta...
ziv-aflibercept
leucovorin calc...
fluorouracil
laboratory biom...
18 Years - University of Southern California
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal MalignanciesNCT01643499
Acinar Cell Ade...
Adenocarcinoma ...
Adenocarcinoma ...
Adult Primary C...
Advanced Adult ...
Cholangiocarcin...
Cholangiocarcin...
Diffuse Adenoca...
Duct Cell Adeno...
Intestinal Aden...
Localized Unres...
Metastatic Carc...
Metastatic Extr...
Mixed Adenocarc...
Mucinous Adenoc...
Mucinous Adenoc...
Newly Diagnosed...
Signet Ring Ade...
Signet Ring Ade...
Stage III Pancr...
Stage IIIA Colo...
Stage IIIA Gall...
Stage IIIA Gast...
Stage IIIA Rect...
Stage IIIB Colo...
Stage IIIB Gall...
Stage IIIB Gast...
Stage IIIB Rect...
Stage IIIC Colo...
Stage IIIC Gast...
Stage IIIC Rect...
Stage IV Gastri...
Stage IV Pancre...
Stage IVA Colon...
Stage IVA Gallb...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Gallb...
Stage IVB Recta...
Unresectable Ex...
oxaliplatin
irinotecan hydr...
leucovorin calc...
fluorouracil
laboratory biom...
18 Years - University of Chicago
Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal CancerNCT01403103
Mucinous Adenoc...
Mucinous Adenoc...
Signet Ring Ade...
Signet Ring Ade...
Stage I Colon C...
Stage I Rectal ...
cholecalciferol
biopsy
protein express...
enzyme-linked i...
laboratory biom...
reverse transcr...
18 Years - Case Comprehensive Cancer Center
Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal CancerNCT01403103
Mucinous Adenoc...
Mucinous Adenoc...
Signet Ring Ade...
Signet Ring Ade...
Stage I Colon C...
Stage I Rectal ...
cholecalciferol
biopsy
protein express...
enzyme-linked i...
laboratory biom...
reverse transcr...
18 Years - Case Comprehensive Cancer Center
Gene Therapy in Treating Patients With CancerNCT00004178
Cancer
therapeutic aut...
18 Years - Roger Williams Medical Center
Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal CancerNCT00002896
Colorectal Canc...
chemotherapy
fluorouracil
leucovorin calc...
conventional su...
low-LET cobalt-...
low-LET photon ...
- 75 YearsNational Cancer Institute (NCI)
Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal CancerNCT01285102
Liver Metastase...
Mucinous Adenoc...
Mucinous Adenoc...
Recurrent Colon...
Recurrent Recta...
Signet Ring Ade...
Signet Ring Ade...
Stage IV Colon ...
Stage IV Rectal...
irinotecan-elut...
hepatic artery ...
18 Years - Fox Chase Cancer Center
CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryNCT02232152
Mucinous Adenoc...
Mucinous Adenoc...
Recurrent Colon...
Recurrent Recta...
Signet Ring Ade...
Signet Ring Ade...
Stage IIIA Colo...
Stage IIIA Rect...
Stage IIIB Colo...
Stage IIIB Rect...
Stage IIIC Colo...
Stage IIIC Rect...
Stage IVA Colon...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Recta...
6,8-bis(benzylt...
fluorouracil
pharmacological...
laboratory biom...
18 Years - Wake Forest University Health Sciences
Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing ChemoradiationNCT02132858
Mucinous Adenoc...
Recurrent Recta...
Signet Ring Ade...
Stage IIA Recta...
Stage IIB Recta...
Stage IIC Recta...
Stage IIIA Rect...
Stage IIIB Rect...
Stage IIIC Rect...
cytology specim...
laboratory biom...
18 Years - Fox Chase Cancer Center
Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal CancerNCT01871571
Mucinous Adenoc...
Signet Ring Ade...
Stage IIA Recta...
Stage IIB Recta...
Stage IIC Recta...
Stage IIIA Rect...
Stage IIIB Rect...
Stage IIIC Rect...
bevacizumab
oxaliplatin
leucovorin calc...
fluorouracil
laboratory biom...
18 Years - University of Southern California
Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal CancerNCT00003799
Adenocarcinoma ...
Mucinous Adenoc...
Signet Ring Ade...
Stage IIA Recta...
Stage IIB Recta...
Stage IIC Recta...
Stage IIIA Rect...
Stage IIIB Rect...
Stage IIIC Rect...
fluorouracil
oxaliplatin
radiation thera...
leucovorin calc...
therapeutic con...
18 Years - National Cancer Institute (NCI)
Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal CancerNCT02270606
Mucinous Adenoc...
Recurrent Recta...
Signet Ring Ade...
Rectal Adenocar...
Stage IIA Recta...
Stage IIB Recta...
Stage IIC Recta...
Stage IIIA Rect...
Stage IIIB Rect...
Stage IIIC Rect...
intensity-modul...
fluorouracil
oxaliplatin
leucovorin calc...
therapeutic con...
18 Years - Virginia Commonwealth University
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal CancerNCT01652196
Mucinous Adenoc...
Mucinous Adenoc...
Signet Ring Ade...
Signet Ring Ade...
Stage IV Colon ...
Stage IV Rectal...
aflibercept
oxaliplatin
leucovorin
fluorouracil
Correlative Stu...
DCE MRI
f18FDG-PET
PET (positron e...
18 Years - Ohio State University Comprehensive Cancer Center
Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal CancerNCT00052585
Adenocarcinoma ...
Adenocarcinoma ...
Mucinous Adenoc...
Mucinous Adenoc...
Recurrent Colon...
Recurrent Recta...
Signet Ring Ade...
Signet Ring Ade...
Stage IV Colon ...
Stage IV Rectal...
irinotecan hydr...
gefitinib
leucovorin calc...
fluorouracil
18 Years - National Cancer Institute (NCI)
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal CancerNCT01652196
Mucinous Adenoc...
Mucinous Adenoc...
Signet Ring Ade...
Signet Ring Ade...
Stage IV Colon ...
Stage IV Rectal...
aflibercept
oxaliplatin
leucovorin
fluorouracil
Correlative Stu...
DCE MRI
f18FDG-PET
PET (positron e...
18 Years - Ohio State University Comprehensive Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: